A proposed federal budget could cut $715 billion from Medicaid, leaving 8.6 million Americans without insurance. Learn how this impacts cancer prevention, early detection, and survival—and what you can do to help protect care access.
Learn how the Colorectal Cancer Alliance is advocating for the passage of the Nancy Gardner Sewell Multi-Cancer Early Detection Act (HR 2407), a bipartisan bill that ensures immediate Medicare coverage for life-saving cancer detection tests once approved by the FDA.
Around her 32nd birthday, Jen Waller started noticing symptoms associated with colorectal cancer, including abdominal pain, weight loss, and irregularity with bowel movements.
Two stories occurring decades apart bookend one Virginia survivor’s journey with colorectal cancer. The first story takes place shortly before humans walked on the moon. The last happened just the other day.
Although there is no single cause of colon cancer or rectal cancer, one in 24 people will be diagnosed with colorectal cancer in their lifetime, and certain factors can push your risk even higher.
After losing their sister Meredith to colorectal cancer, Kathryn and Abigail are turning grief into advocacy. Their powerful story highlights the urgent need for CRC awareness and action — especially among young adults who are facing rising rates of this disease.
This month, the Centers for Medicare & Medicaid Services (CMS) issued its final National Coverage Decision for Cologuard, making it the first FDA-approved stool DNA test for the detection of colon cancer and precancer covered for Medicare patients throughout the country.
We were thrilled to see all the conversation around the recent announcement about the FDA clearance of Given Imaging’s PillCam COLON as a new colon exam tool.
Several different types of colonoscopy prep regimens are available today, including prescription and over-the-counter options. While it is important to consult your healthcare provider for guidance, it can be helpful to conduct some of your own research.
The company wants to ensure it is medically necessary and makes financial sense. At the same time, however, companies should use prior authorization judiciously as it can delay necessary treatment or cause patients to abandon the procedure altogether.
Some polyps can be dangerous and may lead to certain cancers, including colorectal cancer. It is important to know the warning signs of polyps and how to seek testing and treatment.
The Centers for Medicare and Medicaid Services (CMS) finalized the 2023 Physician Fee Schedule reducing the screening age to 45. Now, starting in January, under The Affordable Care Act (ACA) all private health insurance plans (except those grandfathered prior to the ACA) must provide coverage for a screening colonoscopy without co-pay or co-insurance beginning at age 45.
“This a step toward providing people with an incredibly convenient and simple way to get checked for colorectal cancer,” said Michael Sapienza, CEO of the Colorectal Cancer Alliance.
Karen was determined to be vocal about her cancer. The fact that she worked in the medical field and yet knew practically nothing about colorectal cancer was telling to her.